These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 4016772

  • 21. Evaluation of Mannich bases of styryl ketones and related hydrazones for activity against P388 leukemia.
    Dimmock JR, Jonnalagadda SS, Leek DM, Warrington RC, Fang WD.
    Neoplasma; 1988; 35(6):715-24. PubMed ID: 3221938
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 23. [Antitumor activity of trewiasine in vitro and in vivo].
    Yang JL, Shen ZM, Lu LJ, Han JX, Xu CH.
    Zhongguo Yao Li Xue Bao; 1988 Nov; 9(6):508-11. PubMed ID: 3256213
    [No Abstract] [Full Text] [Related]

  • 24. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
    Yamaguchi T, Nakagawa M, Hidaka K, Yoshida T, Sasaki T, Akiyama S, Kuwano M.
    Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
    [Abstract] [Full Text] [Related]

  • 25. [Animal experimental examination of a phase III study on the effect of the combination therapy of bruneomycin, cytostasan and prednisone].
    Nowak C, Arnold W, Henneberger G, Tanneberger S.
    Arch Geschwulstforsch; 1983 Oct; 53(1):37-44. PubMed ID: 6344835
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. New potential cytotoxic and antitumor substances. III. In vitro effect of 3-benzazepine derivatives on P388 cells.
    Fuska J, Fusková A, Proksa B.
    Neoplasma; 1980 Oct; 27(6):703-9. PubMed ID: 7254426
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Role of intracellular pH in the development of resistance of leukemic cells to antineoplastic drugs].
    Shestova OL, Ogloblina TA, Litinskaia LL.
    Eksp Onkol; 1990 Oct; 12(3):61-2. PubMed ID: 2344828
    [Abstract] [Full Text] [Related]

  • 30. Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388.
    Parchure M, Ambaye RY, Gokhale SV.
    Chemotherapy; 1984 Oct; 30(2):119-24. PubMed ID: 6697813
    [Abstract] [Full Text] [Related]

  • 31. Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound.
    Barbieri F, Viale M, Sparatore F, Favre A, Cagnoli M, Bruzzo C, Novelli F, Alama A.
    Anticancer Res; 2000 Oct; 20(2A):977-80. PubMed ID: 10810384
    [Abstract] [Full Text] [Related]

  • 32. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
    Ganu UK, Khandalekar DD, Gokhale SV.
    Indian J Physiol Pharmacol; 1984 Oct; 28(1):21-6. PubMed ID: 6490126
    [Abstract] [Full Text] [Related]

  • 33. Is the P388 murine tumor no longer adequate as a drug discovery model?
    Corbett TH, Valeriote FA, Baker LH.
    Invest New Drugs; 1987 Oct; 5(1):3-20. PubMed ID: 3298130
    [No Abstract] [Full Text] [Related]

  • 34. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F, Decaestecker C, Gaussin JF, Mortier S, Van Ginckel R, Kiss R.
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [Abstract] [Full Text] [Related]

  • 35. Effect of mouse hepatitis virus infection on combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH, DeKoning TF, Nicholas JA, Kramer GD, Wilson D, Wallace TL, Collins MJ.
    Lab Anim Sci; 1987 Feb; 37(1):41-4. PubMed ID: 3035278
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vivo antitumor activity of the bitter melon (Momordica charantia).
    Jilka C, Strifler B, Fortner GW, Hays EF, Takemoto DJ.
    Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV, Sitdikova SM, Kabieva AO.
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [Abstract] [Full Text] [Related]

  • 40. New substances with cytotoxic and antitumor effects. IV. In vitro effect of some veratrum alkaloids and their derivatives on leukemia P388 cells.
    Fuska J, Fusková A, Vassová A, Votický Z.
    Neoplasma; 1981 Sep; 28(6):709-14. PubMed ID: 7339499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.